Lann E Thompson, LCSW | |
705 Riley Hospital Dr, Ri 5837, Indianapolis, IN 46202-5109 | |
(317) 944-8167 | |
(317) 944-9760 |
Full Name | Lann E Thompson |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 705 Riley Hospital Dr, Indianapolis, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013155548 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 35001019A (Indiana) | Secondary |
1041C0700X | Social Worker - Clinical | 34001870A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lann E Thompson, LCSW Po Box 1026, Indianapolis, IN 46206-1026 Ph: (317) 274-1201 | Lann E Thompson, LCSW 705 Riley Hospital Dr, Ri 5837, Indianapolis, IN 46202-5109 Ph: (317) 944-8167 |
News Archive
Scientists have investigated the presence of specific biomarkers in hospitalized COVID-19 patients
A simple 'traffic light' test that detects hidden liver fibrosis and cirrhosis in high risk populations could reduce harmful drinking rates and potentially prevent hundreds of alcohol-related deaths a year.
The open-access journal PLoS Neglected Tropical Diseases on Tuesday "published a comprehensive report showcasing the disproportionately high burden of neglected tropical diseases (NTDs) in India and South Asia," the Global Network for Neglected Tropical Disease's "End the Neglect" blog reports.
Endoscopic sleeve gastroplasty, a relatively new, minimally invasive weight-loss procedure, resulted in significant total body weight loss in the first long-term study to follow patients' progress over five years, according to research presented at Digestive Disease Week 2019.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
› Verified 2 days ago